logo
Michael Bloomberg tops the list of America's biggest donors for the second year in a row

Michael Bloomberg tops the list of America's biggest donors for the second year in a row

The Hill04-03-2025

For the second year in a row, former New York City mayor Michael Bloomberg gave the most to charitable causes, according to the Chronicle of Philanthropy's exclusive Philanthropy 50 list of the Americans who donated the largest sums to nonprofits last year.
In 2024, he gave a total of $3.7 billion to support arts, education, the environment, public-health groups, and programs aimed at improving city governments. He gives directly to charities and through his Bloomberg Philanthropies, which last year awarded a $1 billion grant to his alma mater, Johns Hopkins University, to make medical school free and to provide financial aid to nursing and public health students.
'I've never understood people who wait until they die to give away their wealth. Why deny yourself the satisfaction?' he wrote in an email to the Chronicle. 'I've been very lucky, and I'm determined to do what I can to open doors for others and to leave a better world for my children and grandchildren.'
Bloomberg was one of six donors who gave $1 billion or more in 2024. The others were Netflix co-founder Reed Hastings and his wife, Patty Quillin (No. 2), Dell Technologies founder Michael Dell and his wife, Susan Dell (No. 3), investor Warren Buffett (No. 4), Facebook co-founder Mark Zuckerberg and his wife, physician Priscilla Chan (No. 5), and retired professor Ruth Gottesman (No. 6).
The majority of those gifts went to foundations and donor-advised funds that support causes including education, economic mobility, social justice, and scientific research. Gottesman, like Bloomberg, gave to make medical school free. She donated $1 billion to the Albert Einstein College of Medicine.
Together the 50 donors on the list contributed a total of $16.2 billion to charity in 2024. The median amount they gave was $100 million.
While those numbers are sizable, not all of the nation's wealthiest people appear on the list. Only 19 of the richest Americans on the Forbes 400 list donated enough to appear in the Philanthropy rankings.
Among those who gave big — but are less well known:
— Thomas Golisano, the billionaire founder of Paychex, is No. 8. He gave away $500 million last year. Almost $400 million of that went to 123 nonprofits in New York and Florida with no strings attached. About 90 of those gifts were $1 million to $5 million, often to small groups that rarely get contributions of that size. Many were to organizations that serve people with developmental, intellectual, and physical disabilities. The issue has great meaning to Golisano, whose son has a developmental disability.
— Retired insurance executive Hyatt Brown and his wife, Cici, at No. 20, gave the Museum of Arts & Sciences, in Daytona Beach, Fla., $150 million for a new building and to turn its current home into a children's museum.
— Businesswoman and venture capital investor Michele Kang, at No. 28, gave $84 million last year, including $4 million to help the USA Women's Rugby Sevens team prepare for the Olympics.
Some big public debates have been swirling in the world of philanthropy. Some donors — most notably hedge-fund billionaire Bill Ackman — pushed back against the institutions they have supported, criticizing universities' responses to the October 7 attacks in Israel and campus protests against the war in Gaza; critiquing diversity, equity, and inclusion programs; demanding changes; and pledging to halt support.
Some philanthropists believe that politicized public debates about giving are unhelpful noise that can get in the way of doing effective work. K. Lisa Yang (No. 34), a retired investment banker, gave $74.5 million this year, much of that to MIT and Cornell University, where she is a trustee.
Over the years, Yang has given large sums to programs that help people who are physically or cognitively disabled, and she advocates for individuals with disabilities and autism-spectrum disorders.
'The people who are suffering from these disorders, they don't have the luxury of time,' she says. 'When you have a rare disease and they do politics, to the people who are suffering from the disorder, it is totally irrelevant. They're still suffering.'
But some donors are loath to get ensnared in high-profile polarizing issues, says Renee Kaplan, CEO of the donor advisory firm Forward Global. As a result, she says, some donors are staying out of the fray by making anonymous gifts. Others are working together in donor collaboratives, both to boost their power and resources and to shield individual contributors from criticism.
Donors are starting to say, 'I'll do more anonymously. I'm not going to put my name on things. I'm going to slow down our foundation for a while because I'm worried I'll be a target,' Kaplan says. 'I think there's genuine concern and pause and fear that's affecting donors.'
This year's list marks the 25th anniversary of the Philanthropy 50 ranking. Buffett was the top donor over that period, with cumulative gifts totaling $49.4 billion. Microsoft co-founder Bill Gates and Melinda French Gates followed, with the $34 billion they gave together. (Since their divorce, both have appeared on the list individually.) Bloomberg, Jeff Bezos, and Elon Musk round out the top five.
Buffett, Gates and French Gates, and Bloomberg together account for roughly one-third of the $314.5 billion in giving by Philanthropy 50 donors since 2000. The biggest gift made during that time is Buffett's 2006 pledge to the Gates Foundation, valued at the time at $36.1 billion.
Associated Press coverage of philanthropy and nonprofits receives support through the AP's collaboration with The Conversation US, with funding from Lilly Endowment Inc. The AP is solely responsible for this content. For all of AP's philanthropy coverage, visit https://apnews.com/hub/philanthropy.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tesla's Optimus robot VP is leaving the company
Tesla's Optimus robot VP is leaving the company

Yahoo

timean hour ago

  • Yahoo

Tesla's Optimus robot VP is leaving the company

The head of Tesla's Optimus humanoid robot program, Milan Kovac, is leaving the company. Kovac said Friday in a post on X that he "had to make the most difficult decision" of his life to leave. "I've been far away from home for too long, and will need to spend more time with family abroad," he wrote. Kovac said that was "the only reason" and that his support for Musk and Tesla is "ironclad." Kovac's departure was first reported Friday by Bloomberg News. The departure comes as Tesla CEO Elon Musk has claimed the company will have "thousands" of Optimus robots operating in its factories by the end of this year. "And we expect to scale Optimus up faster than any product, I think, in history, to get to millions of units per year as soon as possible," Musk said last month. Kovac worked at Tesla for nearly 10 years, with much of that time coming as a top engineer on the Autopilot team. He was tapped to help lead development of Optimus in 2022 and became a vice president overseeing the program in late 2024. "I'm driving the Optimus program (Tesla's humanoid robot) & all its engineering teams," Kovac previously wrote on his LinkedIn profile. "Separately, I'm also driving the engineering teams responsible for all the software foundations & infrastructure common between Optimus and Autopilot." Ashok Elluswamy, the vice president of Tesla's AI software division, will take over the Optimus project, according to Bloomberg. This story has been updated with information from Kovac's X post about his departure.

Nucleus Genomics Launches Nucleus Embryo, Genetic Optimization Software Alongside Partnership with Genomic Prediction
Nucleus Genomics Launches Nucleus Embryo, Genetic Optimization Software Alongside Partnership with Genomic Prediction

Yahoo

time2 hours ago

  • Yahoo

Nucleus Genomics Launches Nucleus Embryo, Genetic Optimization Software Alongside Partnership with Genomic Prediction

Parents pursuing IVF now have a new level of choice to empower their family planning NEW YORK, June 4, 2025 /PRNewswire/ -- With U.S. birthrates plummeting and IVF on the rise, Nucleus Genomics today launched Nucleus Embryo, the first genetic optimization software that lets parents see and understand a complete genetic profile to select an embryo. "Before there's a heartbeat, there's DNA," said Kian Sadeghi, founder and CEO of Nucleus. "One file containing DNA and genetic markers can tell you more about your baby's future than any other test a doctor could possibly run at this stage. Most clinics stop at whether an embryo will develop. For many parents, that's not enough. Patients have long asked for more transparency from clinics, and Nucleus Embryo is an important step toward complete data ownership for parents planning their families." The software enables parents to analyze and compare up to 20 embryos across over 900 hereditary conditions and 40 additional analyses beyond basic viability, spanning cancers, chronic conditions, appearance, cognitive ability, mental health, and more. To widen access to the software, Nucleus will partner with Genomic Prediction, the first company to offer genome-wide screening on embryos. The partnership sets a new standard in genetic medicine, continuing Genomic Prediction's decade-long history of giving hopeful parents the best possible chance of implanting healthy embryos. The company's analyses focus on hereditary conditions, acting as the first line of defense against chronic and rare diseases. "As an organization, we are committed to supporting patients' rights to their DNA and any information that can aid in their family-building journey," said Kelly Ketterson, CEO of Genomic Prediction. "We have a legacy of innovation aimed at providing patients with access to the best scientific resources. Our partnership with Nucleus opens access to information our patients have requested and allows us to uphold our commitment to this legacy." Nucleus' partnership with Genomic Prediction reflects a growing shift in how parents think about genetics as a tool to give children the best possible start in life. A wide-ranging study of Americans found the majority accepted the use of genetic technology to choose embryos based on health and personality traits. Four in 10 parents would use genetic optimization as another tool to understand their future child's cognitive abilities. Most women undergo three to six IVF cycles before successfully having a baby, with each cycle costing up to $25,000. Many embryos are unviable within days of being fertilized, leaving parents with few to choose from. Facing high stakes, clinicians often recommend genetic testing to optimize a couple's chances of a healthy pregnancy. But these tests typically stop at a select number of hereditary conditions and chromosome count. Now, advanced genetic analysis from Nucleus gives parents a new window into the health and well-being of their future child. Nucleus Embryo provides a comprehensive genetic profile for each embryo, encompassing hereditary genetic diseases, like cystic fibrosis and hemochromatosis, alongside genetic measures of cognitive ability, mental health, and risk for chronic diseases. Wide access to genetic insights for embryos can also help extend lifespan from the earliest stages of life. While more than half of all deaths annually in the U.S. are attributed to chronic, age-related conditions — such as Alzheimer's disease, diabetes, cancer, and heart disease — research shows embryonic selection can materially help reduce disease risk for these conditions. "We celebrate health optimization and the pursuit of longevity in every other part of life via our focus on training, supplements, and sleep," Sadeghi said. "We all know health isn't just the absence of disease. It's the ability to understand our bodies and genetic makeup to reach our full potential. Now we can apply this principle to life's inception." About Nucleus Genomics Nucleus builds software for generational health. Inspired by the loss of his cousin who died of a rare — yet preventable — genetic disease, Nucleus founder and Thiel Fellow Kian Sadeghi left an Ivy League university to build a product that could have saved her life. Our advanced DNA health test and analysis takes the guesswork out of your health, whether it's perfecting your protocols, knowing your risk for cancer, or planning for a healthy family. Follow us on social media @nucleusgenomics. About Genomic Prediction Genomic Prediction, Inc. is the frontrunner in advanced embryo screening. Our proprietary LifeView platform is state-of-the-art technology that assesses embryos for genetic health aimed at improved IVF outcomes. The LifeView Embryo Health Score Test (EHS) offers insight into the likelihood of developing conditions driven by multiple genes. It tests for significant health issues, including cardiovascular disease, diabetes mellitus, certain cancers, and mental health conditions. The EHS results are derived from the same embryo sample used in the following PGT tests: PGT-A: Identifies chromosome abnormalities in embryos. PGT-A+: Pinpoints the origin (paternal, maternal, or embryonic) of chromosome abnormalities. PGT-M: Decreases the chances of passing on monogenic (single-gene) conditions. PGT-SR: Detects chromosome abnormalities and structural imbalances, providing clarity between normal and balanced chromosomes. View original content to download multimedia: SOURCE Nucleus

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store